Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea

International Journal of Clinical Pharmacology and Therapeutics

Volumn 44, Issue 1, 2006, Pages 14-21

  Dworacka, M ^a   Abramczyk, M ^a   Winiarska, H ^a   Kuczynski, S ^a   Borowska, M ^a   Szczawinska, K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Diabetes mellitus type 2; Proinsulin; Sulfonylureas

Indexed keywords

C PEPTIDE; DIAPREL; DIAPREL MR; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; HUMALOG MIX 25; INSULIN; INSULIN LISPRO; MIXTARD 30; ORAL ANTIDIABETIC AGENT; PREPROINSULIN; PROINSULIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CELL FUNCTION; CELL SECRETION; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; DISEASE DURATION; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; SCORING SYSTEM;

EID: 30644474723     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/cpp44014     Document Type: Article

References (36)

1. Davies MJ, Metcalfe J, Day JL, Grenfell A, Hales CN, Gray IP 1994 Effect of sulfonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus. Diabet Med 11: 293-298
2. Davis SN, Granner DK 2001 Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Hardman JG, Lambird LE, Gilman AG (eds): Goodman and Gilman's: The pharmacological basis of therapeutics. McGraw-Hill, New York, pp 1679-1686
3. Dworacka M, Szczawinska K, Winiarska H, Kuczynski S 1997 The usefulness of 1,5-anhydro-D-glucitol estimation in plasma of patients with type 2 diabetes. Diagnostyka Laboratoryjna 33: 269-276
4. Dworacka M, Winiarska H, Szymanska M, Kuczynski S, Szczawinska K, Wierusz-Wysocka B 2002 1,5-anhydro-D-glucitol: a novel marker of glucose excursions. Intern J Clin Pract 129 (Suppl): 40-44
5. Haffner SM, D'Agostino R, Mykkanen L, Hales CN, Savage PJ, Bergman RN 1998 Proinsulin and insulin concentrations in relation to carotid wall: the insulin resistance atherosclerotic study. Stroke 29: 1498-1503
6. Halban PA, Irminger J-C 2003 Mutant proinsulin that cannot be converted is secreted efficiently from primary rat β-cells via the regulated pathway. Mol Biol Cell 3: 1195-1203
7. Hart LM, Dekker IM, van Haeften TW, Ruige JB, Stehouwer CDA, Erkelens DW 2000 Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with type 2 diabetes mellitus. Diabetologia 4: 515-519
8. Kahn SE, Halban PA 1997 Release of incompletely processed proinsulin in the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46: 1725-1732
9. Keiser N, Leibowitz G, Nesher R 2003 Glucotoxicity and beta-cell failure in type 2 diabetes mellitus. J Pediatr Endocrinol Metab 16: 5-22
10. Kosaka K, Kuzuya T, Akanuma Y, Hagura R 1980 Increase in insulin response after treatment of overt maturity-onset diabetes independent of the mode of treatment. Diabetologia 18: 735-740
11. Langenfeld MR, Forst T, Standl E, Strotmann HJ, Lubben G, Pahler S, Kann P, Pfüzner A 2004 IRIS II Study: sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance. Diabet Technol Ther 6: 836-843
12. Lindhal B, Dinesen B, Eliasson M, Roder M Jansson JH, Huhtasaari F 1999 High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. Metabolism 48: 1197-1202
13. Matthews DR, Hosker JP, Rudensky AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28: 412-419
14. Mykkanen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM 1999 The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type 2 diabetes: the insulin resistance atherosclerosis study. Diabetologia 9: 1060-1067
15. Oh J-Y, Barrett-Connor E, Wedrick NM 2002 Sex differences in the association between proinsulin and intact insulin with coronary heart disease in nondiabetic older adults: the Rancho Bernardo Study. Circulation 105: 1311-1316
16. Pfüzner A, Kann PH, Pfüzner AH, Kunt T, Larbig M, Weber MM, Forst T 2004a Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance. Clin Lab 50: 567-573
17. Pfüzner A, Knut T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T 2004b Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabetes Care 27: 682-687
18. Pfüzner A, Standl E, Hohberg C, Konrad T, Strotmann HJ, Lübben G, Langenfeld MR, Schulze J, Forst T 2005 IRIS II Study: intact proinsulin is confirmed as highly specific indicator for insulin resistance in a large cross-sectional study design. Diabet Tech Ther 3: 478-486
19. Porte D, Kahn SE 1989 Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islets β-cell dysfunction? Diabetes 38: 1333-1336
20. Porte J, Kahn SE 1995 The key role of islet dysfunction in type II diabetes mellitus. Clin Invest Med 18: 247-254
21. Porte D, Kahn SE 2001 Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 50 (Suppl 1): 160-163
22. Prigeon RL, Jacobson RK, Porte D, Kahn SE 1996 Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 3295-3298
23. Roder ME, Vaag A, Harding SG, Dinesen B, Lanng S, Beck-Nielsen H 1995 Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 80: 2359-2363
24. Roder ME, Porte D, Schwartz RS, Kahn SE 1998 Disproportionately elevated proinsulin levels reflect the degree of impaired beta-cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 2: 604-608
25. Saad MF, Kahn SE, Nelson RG, Pettit DJ, Knowler WC Schwartz MW, Kowalyk S, Bennet PH, Porte D 1990 Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 5: 1247-1253
26. Schneider DJ, Nordt TK, Sobel BE 1992 Stimulation by proinsulin of expression of plasminogen activator inhibitor-1 in endothelial cells. Diabetes 41: 890-895
27. Szymanska M, Dworacka M, Winiarska H, Kuczynski S, Szczawinska K 2000 Proinsulin concentration in patients with coronary heart disease (CHD) and diabetes mellitus type 2 is dependent on hypoglycemic therapy. VII World Conference on Clinical Phamacology and Therapeutics IUPHAR - Division of Clinical Pharmacology. Firenze, Italy. Brit J Clin Pharmacol (Abstract), 173
28. Szymanska M, Dworacka M, Szczawinska K 2001 The association between hypoglycaemic therapy and serum proinsulin concentration in patients with type 2 diabetes. The 3rd Meeting of the Federation of the European Pharmacological Societies, Lyon, France. Fund Clin Pharmacol (Abstract), 15
29. The DECODE Study Group for European Diabetes Epidemiology Group 2001 Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161: 397-405
30. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D 1987 Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698-702
31. Yabuuchi M, Masuda M, Katoh K, Nakamura T, Akanauka H 1984 Simple enzymatic method for determining 1,5-anhydro-D-glucitol for diagnosis of diabetes mellitus. Clin Chem 35: 2039-2043
32. Yamanouchi T, Akanuma Y 1994 Serum 1,5-anhydro-D-glucitol: new clinical marker for glycemic control. Diabet Res Clin Pract 24 (Suppl): 261-268
33. Yudkin JS 1997 The Deidesheimer Meeting: significance of classical and new risk factors in non-insulin-dependent diabetes mellitus. J Diabet Complications 11: 100-103
34. Yudkin JS, Denver AE, Mohamed-Ali V, Ramaiya KL, Nagi DK, Goubet S 1997 The relationship of concentrations of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence. A study of two ethnic groups. Diabetes Care 20: 1093-1100
35. Yudkin JS 2002 Increased proinsulin concentrations and excess risk of coronary heart disease in patients with diabetes and prediabetes. Circulation 106: e202
36. Yudkin JS, May M, Elwood P, Yarnell JWG, Greenwood R, Davey Smith G 2002 Concentrations of proinsulin-like molecules predict coronary heart disease independently of insulin: prospective data from Caerphilly Study. Diabetologia 45: 327-336